Clinical Trials in Special Patient Populations

Clinical Trials in Special Patient Populations

The term “special population” exists to protect certain vulnerable patient groups that require additional consideration as it pertains to clinical research, including women, pediatrics, and the elderly.

Regulatory agencies require clinical trial sponsors to present a summary of safety and effectiveness data by demographic subgroups, for age, gender, and ethnicity – because one size does not fit all.

In this webinar, we will explore these different patient populations, outline the challenges to trial recruitment and retention, and overview the regulatory efforts underway to ensure inclusive research.


Annemarie Forrest Annemarie Forrest Director of Projects
Clinical Trials Transformation Initiative (CTTI)

Christina Brennan, MD, MBA Christina Brennan, MD, MBA Vice President of clinical research
The Feinstein Institutes for Medical Research

Jasmine Benger Jasmine Benger Senior Project Manager, Research Services

Ben Hargreaves Ben Hargreaves Editor
in-PharmaTechnologist and BioPharma-Reporter